Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

IVL-DrugFluidic® can mass-produce high-quality, long-acting injectable drug microspheres, improving patient compliance and reducing side effects.

Polish medical societies recommend personalized treatment for PCOS based on the patient's specific symptoms and use the Rotterdam criteria for diagnosis.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

The document's conclusion cannot be provided because the content is not available for analysis.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Platelet Rich Fibrin (PRF) is a safe, effective tool for tissue regeneration and healing in various medical fields.

Papillon-Lefèvre Syndrome causes early tooth loss and skin issues, needing early dental diagnosis.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

PTeCA is a reliable marker for detecting oxidative hair treatments.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.

Enhanced stem cells can reduce fat buildup in eye tissue for Graves' disease.

Using electronic health records can help identify drug side effects but has some limitations.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.

More research is needed on the safety of fathers' drug exposure before conception.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

A new method accurately measures a drug in skin for cancer therapy research.

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Finasteride may reduce prostate cancer risk.

The new micelle formulation delivers acne treatment more effectively and safely than current gels.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.